Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected].

Gluzman-Poltorak Z, Cohen T, Herzog Y, Neufeld G.

J Biol Chem. 2000 Jun 16;275(24):18040-5. Erratum in: J Biol Chem 2000 Sep 22;275(38):29922.

2.
3.

Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes.

Gluzman-Poltorak Z, Cohen T, Shibuya M, Neufeld G.

J Biol Chem. 2001 Jun 1;276(22):18688-94. Epub 2001 Mar 14.

4.

Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.

Sawano A, Takahashi T, Yamaguchi S, Aonuma M, Shibuya M.

Cell Growth Differ. 1996 Feb;7(2):213-21.

5.

Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain.

Mamluk R, Gechtman Z, Kutcher ME, Gasiunas N, Gallagher J, Klagsbrun M.

J Biol Chem. 2002 Jul 5;277(27):24818-25. Epub 2002 May 1.

6.

Cell type-specific expression of neuropilins in an MCA-occlusion model in mice suggests a potential role in post-ischemic brain remodeling.

Beck H, Acker T, PĆ¼schel AW, Fujisawa H, Carmeliet P, Plate KH.

J Neuropathol Exp Neurol. 2002 Apr;61(4):339-50.

PMID:
11939589
7.
8.
9.

The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1.

Fuh G, Garcia KC, de Vos AM.

J Biol Chem. 2000 Sep 1;275(35):26690-5.

10.

Co-expression of vascular endothelial growth factor and neuropilin-1 in ovine feto-placental artery endothelial cells.

Tsoi SC, Wen Y, Chung JY, Chen D, Magness RR, Zheng J.

Mol Cell Endocrinol. 2002 Oct 31;196(1-2):95-106.

PMID:
12385828
11.

Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.

Cao Y, Chen H, Zhou L, Chiang MK, Anand-Apte B, Weatherbee JA, Wang Y, Fang F, Flanagan JG, Tsang ML.

J Biol Chem. 1996 Feb 9;271(6):3154-62.

12.

Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1.

Makinen T, Olofsson B, Karpanen T, Hellman U, Soker S, Klagsbrun M, Eriksson U, Alitalo K.

J Biol Chem. 1999 Jul 23;274(30):21217-22.

13.
14.

Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity.

Gagnon ML, Bielenberg DR, Gechtman Z, Miao HQ, Takashima S, Soker S, Klagsbrun M.

Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2573-8.

15.

Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells.

Gitay-Goren H, Cohen T, Tessler S, Soker S, Gengrinovitch S, Rockwell P, Klagsbrun M, Levi BZ, Neufeld G.

J Biol Chem. 1996 Mar 8;271(10):5519-23.

17.
18.
19.

VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding.

Soker S, Miao HQ, Nomi M, Takashima S, Klagsbrun M.

J Cell Biochem. 2002;85(2):357-68.

PMID:
11948691
20.

Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1.

Wise LM, Veikkola T, Mercer AA, Savory LJ, Fleming SB, Caesar C, Vitali A, Makinen T, Alitalo K, Stacker SA.

Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3071-6.

Supplemental Content

Support Center